Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Innovation1 Biotech's share price for the quarter that ended in Aug. 2023 was $0.85. Innovation1 Biotech's Shares Outstanding (EOP) for the quarter that ended in Aug. 2023 was 20.47 Mil. Therefore, Innovation1 Biotech's market cap for the quarter that ended in Aug. 2023 was $17.40 Mil.
Innovation1 Biotech's quarterly market cap
declined
from Feb. 2023 ($5.41 Mil) to May. 2023 ($3.75 Mil) but then
increased
from May. 2023 ($3.75 Mil) to Aug. 2023 ($17.40 Mil).
Innovation1 Biotech's annual market cap
increased
from Aug. 2021 ($0.57 Mil) to Aug. 2022 ($3.08 Mil) and
increased
from Aug. 2022 ($3.08 Mil) to Aug. 2023 ($17.40 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Innovation1 Biotech's Enterprise Value for Today is $0.21 Mil.
Innovation1 Biotech Market Cap Historical Data
The historical data trend for Innovation1 Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Innovation1 Biotech's Market Cap
For the Shell Companies subindustry, Innovation1 Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovation1 Biotech's Market Cap Distribution in the Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Innovation1 Biotech's Market Cap falls into.
Innovation1 Biotech Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Innovation1 Biotech's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovation1 Biotech (OTCPK:IVBT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Innovation1 Biotech Market Cap Related Terms
Thank you for viewing the detailed overview of Innovation1 Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Innovation1 Biotech (Innovation1 Biotech) Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IVBT has been successfully added to your 